Birdwatch Note
2023-06-07 17:29:32 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
All 3 original Emergency Authorizations were granted approval under 'investigational purposes,' indicating that the products were in the experimental/investigational stage of development until "Full Approval" EUA's Pfizer BNT162b2: https://www.fda.gov/media/144416/download Moderna mRNA-1273: https://www.fda.gov/media/144673/download J&J Ad26.COV2.S: https://www.fda.gov/media/146338/download https://www.federalregister.gov/documents/2021/01/19/2021-01022/authorizations-of-emergency-use-of-two-biological-products-during-the-covid-19-pandemic-availability
Written by D6A676B0D3643EE20AD64E8084317780128241B5DF5F2DFAC8F788683AC435B1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1666176143773298690
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1666497634607980551
- noteId - 1666497634607980551
- participantId -
- noteAuthorParticipantId - D6A676B0D3643EE20AD64E8084317780128241B5DF5F2DFAC8F788683AC435B1 Participant Details
- createdAtMillis - 1686158972776
- tweetId - 1666176143773298690
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- All 3 original Emergency Authorizations were granted approval under 'investigational purposes,' indicating that the products were in the experimental/investigational stage of development until "Full Approval" EUA's Pfizer BNT162b2: https://www.fda.gov/media/144416/download Moderna mRNA-1273: https://www.fda.gov/media/144673/download J&J Ad26.COV2.S: https://www.fda.gov/media/146338/download https://www.federalregister.gov/documents/2021/01/19/2021-01022/authorizations-of-emergency-use-of-two-biological-products-during-the-covid-19-pandemic-availability
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-06-07 17:29:32 UTC (1686158972776) |
1969-12-31 23:59:59 UTC (-1) |
2023-06-08 02:08:54 UTC (1686190134085) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-06-07 16:08:45 -0500 | Rating Details | |
| 2023-06-07 15:48:04 -0500 | Rating Details | |
| 2023-06-07 15:29:06 -0500 | Rating Details | |
| 2023-06-07 15:11:19 -0500 | Rating Details | |
| 2023-06-07 15:09:03 -0500 | Rating Details | |
| 2023-06-07 15:06:59 -0500 | Rating Details | |
| 2023-06-07 15:06:55 -0500 | Rating Details | |
| 2023-06-07 15:06:51 -0500 | Rating Details | |
| 2023-06-07 15:01:54 -0500 | Rating Details | |
| 2023-06-07 14:58:23 -0500 | Rating Details | |
| 2023-06-07 14:56:30 -0500 | Rating Details | |
| 2023-06-07 14:54:19 -0500 | Rating Details | |
| 2023-06-07 14:52:24 -0500 | Rating Details | |
| 2023-06-07 14:51:53 -0500 | Rating Details | |
| 2023-06-07 14:50:31 -0500 | Rating Details | |
| 2023-06-07 14:48:25 -0500 | Rating Details | |
| 2023-06-07 14:46:09 -0500 | Rating Details | |
| 2023-06-07 14:44:59 -0500 | Rating Details | |
| 2023-06-07 14:44:46 -0500 | Rating Details | |
| 2023-06-07 14:43:31 -0500 | Rating Details | |
| 2023-06-07 14:41:37 -0500 | Rating Details | |
| 2023-06-07 14:41:25 -0500 | Rating Details | |
| 2023-06-07 14:41:18 -0500 | Rating Details | |
| 2023-06-07 14:40:57 -0500 | Rating Details | |
| 2023-06-07 14:40:34 -0500 | Rating Details | |
| 2023-06-07 14:39:52 -0500 | Rating Details | |
| 2023-06-07 14:38:57 -0500 | Rating Details | |
| 2023-06-07 14:37:34 -0500 | Rating Details | |
| 2023-06-07 14:30:37 -0500 | Rating Details | |
| 2023-06-07 14:29:42 -0500 | Rating Details | |
| 2023-06-07 14:22:18 -0500 | Rating Details | |
| 2023-06-07 14:21:34 -0500 | Rating Details | |
| 2023-06-07 14:16:08 -0500 | Rating Details | |
| 2023-06-07 14:12:40 -0500 | Rating Details | |
| 2023-06-07 14:09:01 -0500 | Rating Details | |
| 2023-06-07 14:04:59 -0500 | Rating Details | |
| 2023-06-07 14:00:49 -0500 | Rating Details | |
| 2023-06-07 13:57:56 -0500 | Rating Details | |
| 2023-06-07 13:53:56 -0500 | Rating Details | |
| 2023-06-07 13:53:56 -0500 | Rating Details | |
| 2023-06-07 13:53:27 -0500 | Rating Details | |
| 2023-06-07 13:48:56 -0500 | Rating Details | |
| 2023-06-07 13:45:38 -0500 | Rating Details | |
| 2023-06-07 13:37:20 -0500 | Rating Details | |
| 2023-06-07 13:36:12 -0500 | Rating Details | |
| 2023-06-07 13:32:13 -0500 | Rating Details | |
| 2023-06-07 13:31:47 -0500 | Rating Details | |
| 2023-06-07 13:23:41 -0500 | Rating Details | |
| 2023-06-07 13:14:58 -0500 | Rating Details | |
| 2023-06-07 13:11:51 -0500 | Rating Details | |
| 2023-06-07 13:07:53 -0500 | Rating Details | |
| 2023-06-07 13:05:39 -0500 | Rating Details | |
| 2023-06-07 13:03:39 -0500 | Rating Details | |
| 2023-06-07 12:57:39 -0500 | Rating Details | |
| 2023-06-07 12:56:29 -0500 | Rating Details | |
| 2023-06-07 12:53:34 -0500 | Rating Details | |
| 2023-06-07 12:51:23 -0500 | Rating Details | |
| 2023-06-07 12:47:17 -0500 | Rating Details | |
| 2023-06-07 12:37:41 -0500 | Rating Details | |
| 2023-06-08 06:29:47 -0500 | Rating Details | |
| 2023-06-10 04:38:39 -0500 | Rating Details | |
| 2023-06-12 18:02:01 -0500 | Rating Details |